Leiomyosarcomas

Also known as: Leiomyosarcoma (LMS) / LMS - Leiomyosarcoma / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

DrugDrug NameDrug Description
DB00398SorafenibA kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma.
DrugDrug NameTargetType
DB00398SorafenibSerine/threonine-protein kinase B-raftarget
DB00398SorafenibReceptor-type tyrosine-protein kinase FLT3target
DB00398SorafenibRAF proto-oncogene serine/threonine-protein kinasetarget
DB00398SorafenibVascular endothelial growth factor receptor 3target
DB00398SorafenibPlatelet-derived growth factor receptor betatarget
DB00398SorafenibMast/stem cell growth factor receptor Kittarget
DB00398SorafenibVascular endothelial growth factor receptor 2target
DB00398SorafenibCytochrome P450 3A4enzyme
DB00398SorafenibUDP-glucuronosyltransferase 1-9enzyme
DB00398SorafenibCytochrome P450 2B6enzyme
DB00398SorafenibCytochrome P450 2C8enzyme
DB00398SorafenibCytochrome P450 3A5enzyme
DB00398SorafenibCytochrome P450 3A7enzyme
DB00398SorafenibCytochrome P450 2C9enzyme
DB00398SorafenibMultidrug resistance-associated protein 4transporter
DB00398SorafenibP-glycoprotein 1transporter
DB00398SorafenibCanalicular multispecific organic anion transporter 1transporter
DB00398SorafenibATP-binding cassette sub-family G member 2transporter
DB00398SorafenibCytochrome P450 1A2enzyme
DB00398SorafenibCytochrome P450 2C19enzyme
DB00398SorafenibCytochrome P450 2D6enzyme
DB00398SorafenibUDP-glucuronosyltransferase 1-1enzyme
DB00398SorafenibRalA-binding protein 1transporter
DB00398SorafenibFibroblast growth factor receptor 1target
DB00398SorafenibProto-oncogene tyrosine-protein kinase receptor Rettarget
DB00398SorafenibVascular endothelial growth factor receptor 1target
DB00398SorafenibSolute carrier organic anion transporter family member 1B1transporter
DrugDrug NamePhaseStatusCount
DB11945Avelumab1Active Not Recruiting1
DB00851Dacarbazine1Completed1
DB00997Doxorubicin1Withdrawn1
DB00441Gemcitabine1Completed1
DB00441Gemcitabine1Not Yet Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB06043Olaratumab1Withdrawn1
DB09037Pembrolizumab1Terminated1
DB11942Selinexor1Active Not Recruiting1
DB00877Sirolimus1Not Yet Recruiting1
DB05109Trabectedin1Completed1
DB05109Trabectedin1Withdrawn1
DB18080Unesbulin1Completed1
DB17520Vimseltinib1Active Not Recruiting1
DB14707Cemiplimab1 / 2Recruiting1
DB01248Docetaxel1 / 2Recruiting1
DB01248Docetaxel1 / 2Terminated1
DB08871Eribulin1 / 2Active Not Recruiting1
DB00441Gemcitabine1 / 2Terminated1
DB09078Lenvatinib1 / 2Active Not Recruiting1
DB06589Pazopanib1 / 2Terminated1
DB05109Trabectedin1 / 2Recruiting1
DB11794Berzosertib2Completed1
DB00112Bevacizumab2Completed2
DB00958Carboplatin2Completed1
DB04849Cediranib2Active Not Recruiting1
DB12250Cixutumumab2Completed1
DB00851Dacarbazine2Completed1
DB00851Dacarbazine2Recruiting2
DB03619Deoxycholic acid2Terminated1
DB01234Dexamethasone2Completed1
DB00380Dexrazoxane2Completed1
DB09077Dinutuximab2Recruiting1
DB01248Docetaxel2Completed3
DB01248Docetaxel2Withdrawn2
DB00997Doxorubicin2Completed3
DB00997Doxorubicin2Not Yet Recruiting1
DB00997Doxorubicin2Recruiting1
DB00997Doxorubicin2Terminated1
DB11714Durvalumab2Active Not Recruiting1
DB16047Elraglusib2Withdrawn2
DB08871Eribulin2Active Not Recruiting1
DB12091Gadolinium2Recruiting1
DB00441Gemcitabine2Completed4
DB00441Gemcitabine2Recruiting2
DB00441Gemcitabine2Withdrawn2
DB14865Human interleukin-22Recruiting1
DB01181Ifosfamide2Not Yet Recruiting1
DB01006Letrozole2Completed1
DB01006Letrozole2Terminated1
DB09035Nivolumab2Active Not Recruiting2
DB09074Olaparib2Active Not Recruiting1
DB16269Onfekafusp alfa2Recruiting1
DB17116Ontorpacept2Terminated1
DB06589Pazopanib2Completed1
DB17284Pelareorep2Completed1
DB09037Pembrolizumab2Active Not Recruiting1
DB06233Ridaforolimus2Completed1
DB12332Rucaparib2Active Not Recruiting1
DB00398Sorafenib2Completed1
DB01268Sunitinib2Completed1
DB17072Tabelecleucel2Recruiting1
DB13896Talimogene laherparepvec2Active Not Recruiting1
DB05109Trabectedin2Completed3
DB05109Trabectedin2Recruiting1
DB02546Vorinostat2Terminated1
DB00399Zoledronic acid2Recruiting1
DB00531Cyclophosphamide2 / 3Active Not Recruiting1
DB00851Dacarbazine2 / 3Active Not Recruiting1
DB00694Daunorubicin2 / 3Active Not Recruiting1
DB00997Doxorubicin2 / 3Active Not Recruiting1
DB00997Doxorubicin2 / 3Recruiting1
DB01181Ifosfamide2 / 3Active Not Recruiting1
DB12674Lurbinectedin2 / 3Recruiting1
DB06589Pazopanib2 / 3Active Not Recruiting1
DB18080Unesbulin2 / 3Active Not Recruiting1
DB11885Anlotinib3Active Not Recruiting1
DB00851Dacarbazine3Active Not Recruiting1
DB05109Trabectedin3Withdrawn1
DB00445EpirubicinNot AvailableRecruiting1
DB08896RegorafenibNot AvailableRecruiting1
DB17072TabelecleucelNot AvailableNo Longer Available1
DB00853TemozolomideNot AvailableRecruiting1